logo-loader

eSense-Lab set to commercialise alcohol-free sanitiser comprising terpenes after encouraging research results

Last updated: 10:25 27 Nov 2020 AEDT, First published: 10:21 27 Nov 2020 AEDT

esense-Lab Ltd - eSense-Lab set to commercialise alcohol-free sanitiser comprising TRP-ENV and SeaLaria’s red algae after encouraging research results
eSense believes its formula could be extended to full spectrum anti-pathogenic activity

eSense-Lab Ltd (ASX:ESE) is moving towards commercialising an alcohol-free sanitiser comprising two proprietary blend terpene profiles after receiving positive research results at the Central Virology Lab of the Israeli Ministry of Health. 

Testing of eSense’s two proprietary blend terpene profiles, TRP-ENV and TRP-COV, was undertaken to determine their anti-viral activity against HCoV-OC43 corona strain virus in a range of formulas.

Based on the results, eSense-Lab plans to realise a Letter of Intent with SeaLaria with the intention to commercialise an alcohol-free sanitiser comprising TRP-ENV and SeaLaria’s red algae.

‘Promising commercialisation opportunity’

eSense’s chief technology officer Dr’ Eyal Kalo said: “We are pleased with the initial results from our testing at the Israeli Ministry of Health, in particular, the combination of our terpenes with SeaLaria’s red algae.

“This product shows a very promising commercialisation opportunity to create a hand and surface sanitiser that provides added protection while reducing ethanol content, making it safer and easier on the human skin.“

TRP-ENV combined with SeaLaria’s red algae

A combination of TRP-ENV in the presence of SeaLaria’s red algae provided an immediate neutralisation of HCoV-OC43 virus at all tested times – one, three, 10 and 30 minutes - yielding viricidal activity with a neutralisation efficiency at least as good as 70% ethanol.

HCoV-OC43 is a weak strain of human coronavirus, which represents an accepted surrogate to evaluate activity of substances against SARS-CoV-2 - the virus that causes COVID-19.

The results found more effective antiviral activity in the TRP-ENV profile than in the TRP-COV profile.

This research was to confirm whether the addition of terpenes in sanitisers could mean a reduction of harmful effects on skin, without compromising effectiveness.

The commercial goal is to develop a superior organic dominant sanitiser product that provides added protection against bacteria and viruses, while reducing the ethanol content, which is known for its harmful side effects to the skin and its flammability risks.

Widen research activity

Based on these results, the company plans to widen its research activity by testing around TRPENV activity for bactericidal effect against most common air-born bacteria.

eSense believes its formula could be extended to full-spectrum anti-pathogenic activity (virus and bacteria), which may have the potential to completely replace or at least significantly reduce the necessity for ethanol in hand and surface sterilisation.

OzAurum to start drilling at Boca Rica Lithium Project

OzAurum Resources Ltd (ASX:OZM) CEO and managing director Andrew Pumphrey sits down with Proactive’s Jonathan Jackson to discuss an upcoming drilling program at Boca Rica Lithium Project in Brazil, following the identification of a spodumene zone. The company plans to start drilling in the next...

4 hours, 39 minutes ago